Tyson Foods, Inc. (NYSE:TSN – Get Rating) insider Shane Miller sold 6,608 shares of the firm’s stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $67.75, for a total value of $447,692.00. Following the completion of the transaction, the insider now owns 30,921 shares of the company’s stock, valued at approximately $2,094,897.75. The sale was disclosed in a document filed with the SEC, which is available through this link.

Stock analysts at Credit Suisse Group started coverage on shares of HubSpot (NYSE:HUBS – Get Rating) in a research report issued on Monday, The Fly reports. The brokerage set an “outperform” rating and a $400.00 price target on the software maker’s stock. Credit Suisse Group’s price objective would suggest a potential upside of 51.61% from the company’s previous close.

Microsoft (NASDAQ:MSFT – Get Rating) has been given a $300.00 price target by analysts at UBS Group in a research note issued to investors on Monday, Borsen Zeitung reports. UBS Group’s target price indicates a potential upside of 23.94% from the stock’s previous close.

NVIDIA (NASDAQ:NVDA – Get Rating) had its price objective increased by equities research analysts at Barclays to $170.00 in a research note issued to investors on Monday, Stock Target Advisor reports. Barclays’s price objective suggests a potential upside of 10.70% from the stock’s previous close.

Southern (NYSE:SO – Get Rating) had its price target reduced by research analysts at UBS Group to $80.00 in a report released on Monday, Stock Target Advisor reports. UBS Group’s price objective suggests a potential upside of 22.17% from the company’s current price.

Repare Therapeutics Inc. (NASDAQ:RPTX – Get Rating) – HC Wainwright lifted their FY2022 earnings estimates for Repare Therapeutics in a research report issued to clients and investors on Thursday, November 17th. HC Wainwright analyst R. Burns now expects that the company will earn ($0.88) per share for the year, up from their previous forecast of ($3.71). HC Wainwright has a “Buy” rating and a $25.00 price target on the stock. The consensus estimate for Repare Therapeutics’ current full-year earnings is ($0.69) per share. HC Wainwright also issued estimates for Repare Therapeutics’ Q4 2022 earnings at ($0.95) EPS, Q1 2023 earnings at ($0.98) EPS, Q2 2023 earnings at ($1.01) EPS, Q3 2023 earnings at ($1.03) EPS, Q4 2023 earnings at ($1.06) EPS and FY2023 earnings at ($4.07) EPS.

ViewRay, Inc. (NASDAQ:VRAY – Get Rating) – Research analysts at B. Riley issued their FY2022 earnings per share (EPS) estimates for shares of ViewRay in a note issued to investors on Wednesday, November 16th. B. Riley analyst N. Chatterji expects that the company will earn ($0.61) per share for the year. B. Riley has a “Buy” rating on the stock. The consensus estimate for ViewRay’s current full-year earnings is ($0.59) per share. B. Riley also issued estimates for ViewRay’s Q4 2022 earnings at ($0.17) EPS and FY2023 earnings at ($0.59) EPS.

Equities researchers at Piper Sandler initiated coverage on shares of Cue Biopharma (NASDAQ:CUE – Get Rating) in a research report issued on Sunday, The Fly reports. The brokerage set an “overweight” rating on the stock.

Yelp Inc. (NYSE:YELP – Get Rating) has been assigned a consensus recommendation of “Hold” from the ten research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $38.00.

Biohaven Ltd. (NYSE:BHVN – Get Rating) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,920,000 shares, an increase of 8.6% from the October 15th total of 2,690,000 shares. Based on an average daily volume of 2,610,000 shares, the days-to-cover ratio is presently 1.1 days. Approximately 11.3% of the shares of the company are sold short.